CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍClinical Study Agreement • January 15th, 2024
Contract Type FiledJanuary 15th, 2024PAREXEL International (IRL) Limited, with a place of business at 70 Sir John Rogerson's Quay Dublin 2, Ireland, company registration number: 541507, VAT number:
RÚ: 120.00880145Clinical Study Agreement • October 25th, 2019
Contract Type FiledOctober 25th, 2019CLINICAL STUDY AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ between mezi PAREXEL International (IRL) Limited PAREXEL International (IRL) Limited and a Revmatologický ústav Revmatologický ústav Pfizer Protocol # B7931030 Protokol společnosti Pfizer č. B7931030 This Clinical Study Agreement (“Agreement”) between Tato Smlouva o klinickém hodnocení (dále jen „smlouva“) uzavřená mezi PAREXEL International (IRL) Limited,with a place of business at70 Sir John Rogerson's Quay Dublin 2Ireland Company Number: 541507 VAT Number: IE 3249971HH (“CRO”) PAREXEL International (IRL) Limited, se sídlem70 Sir John Rogerson's Quay Dublin 2Irsko Registrační č. společnosti: 541507 DIČ DPH: IE 3249971HH(dále jen „CRO“) and a Revmatologický ústavState-subsidized organization,with a place of business at Na Slupi 450/4, 128 50 Praha 2, Czech RepublicCompany Registration No.: 00023728 VAT ID No.: CZ00023728Bank account No: 439021/0710 at Czec